April 20 (UPI) — Testing a person’s blood for the presence of circulating melanoma cells may help identify skin cancer, while allowing them to skip invasive biopsies, a study published Wednesday found.
The test uses a technology called Melanoma-specific OncoBean and employs antibodies, or proteins produced by the immune system to fight off diseases, related to the form of skin cancer, researchers said.
- Advertisement -